Video

Dr Richard J. Willke Discusses Challenges of Working With Real-World Data

When using real-world data, researchers must be careful to avoid several common pitfalls that can bias their results, according to Richard J. Willke, PhD, chief science officer of ISPOR.

When using real-world data, researchers must be careful to avoid several common pitfalls that can bias their results, according to Richard J. Willke, PhD, chief science officer of ISPOR.

Transcript (slightly modified)

What are the challenges of working with real-world data? Do the benefits outweigh the negatives?

There are usually 3 challenges in working with real-world data. One is careful data collection. “Garbage in, garbage out” applies here. Another is the lack of randomization, of course, and that’s where we have a lot of different study methods and analytic methods that can be applied to correct for confounding and selection biases. Another one that we’ve seen is that there tend to be a lot of results generated from real-world data, and some people call that data-dredging. The danger is to pay more attention to results that you like than what you don’t.

But, the benefits are that you can find out, as I said a minute ago, things that you can’t find out with randomized clinical trial data, how it actually performs in patients. So, it has to be viewed, as I said, in a complementary sense. How does the real-world data track versus the randomized controlled trial data, and then you try to make decisions about how they fit together.

Related Videos
Picture of San Diego skyline with words ASH Annual Meeting 2024 and health icons overlaid on the bottom
Screenshot of an interview with Amir Ali, PharmD, BCOP
Mansi Shah, MD, assistant professor, Rutgers Cancer Institute of New Jersey
 Alvaro Alencar, MD, associate professor of clinical medicine, chief medical officer, University of Miami Sylvester Comprehensive Cancer Center
Dr Cesar Davila-Chapa
Screenshot of an interview with Nadine Barrett, PhD
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Mabel Mardones, MD.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo